跳至主要内容
临床试验/IRCT20190810044500N11
IRCT20190810044500N11已完成3 期

Topical Timolol Effectiveness for prophylaxy of radiation induced dermatitis in breast cancer patients

Yazd University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Patients older than 18 years with positive histology confirm invasive and localized breast cancer, who are candidates for adjuvant radiotherapy after surgery (breast conserving or mastectomy).
  • Adequate literacy to fill out a consent form, understand the study, use the drug, report pain and possible side effects

排除标准

  • Inflammatory or metastatic carcinoma
  • Extensive skin diseases
  • Connective tissue diseases
  • known sensitivity to beta-antagonist drugs

研究者

发起方
Yazd University of Medical Sciences

相似试验

Topical Timolol Effectiveness for prophylaxy of ... | 临床试验